Professional
Added to YB: 2026-04-24
Pitch date: 2026-02-22
RPID [neutral]
Rapid Micro Biosystems, Inc.
-40.94%
current return
Author Info
No bio for this author
Company Info
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally.
Market Cap
$100.2M
Pitch Price
$3.81
Price Target
N/A
Dividend
N/A
EV/EBITDA
-2.00
P/E
-2.08
EV/Sales
2.54
Sector
Life Sciences Tools and Services
Category
growth
White Brook Capital Partners Portfolio Holding: Rapid Micro Biosystems, Inc.
RPID (holding update): Q4 guidance conservative despite momentum w/ Amgen, Samsung Biologics, Merck Millipore rollouts. Large contract extends to Feb '27 vs Dec '26, some machines may slip to next year. No assurance on new large deal. Gross margin upside expected 2Q'26 from new vendor agreements. Mgmt exceptionally conservative. Best risk/reward in portfolio.
Read full article (1 min)